ALFA Filings
Every announcement, straight from the exchange
Every Curis Lifesciences other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements
Curis Lifesciences Limited informed that it is not required to submit a Corporate Governance Report, as its securities are listed on the SME platform.
Curis Lifesciences Limited submitted the RTA confirmation certificate for the quarter ended June 30, 2026, as required under SEBI Regulation 74(5).
Curis Lifesciences Limited filed its annual SDD compliance certificate for FY2026. The company confirmed full adherence to SEBI Insider Trading regulations regarding digital databases.
Curis Lifesciences Limited confirmed its non-applicability as a Large Corporate for FY 2026-27. This regulatory filing clarifies the company is exempt from SEBI debt-raising framework requirements.
Curis Lifesciences Limited confirmed its non-applicability as a Large Corporate for FY 2026-27. This regulatory filing streamlines compliance requirements for future debt issuances.
Curis Lifesciences Limited informed the exchange regarding the non-applicability of Corporate Governance and Annual Secretarial Compliance Report requirements for the period ended March 31, 2026. As an NSE SME listed company, it is exempt under Regulation 15(2) of SEBI LODR Regulations, 2015.